Tianjin Tianyao Pharmaceuticals Co., Ltd.
SHH: 600488.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Shuxiang Li
- Employees
- 2,678
- Headquarters
- Tianjin, China
- IPO year
- 2001
- Market cap
- CN¥6.6B
- Website
- https://www.tjpcty.com
Loading 600488…
Loading profile data…Frequently asked questions about 600488
What does Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) do?
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone a...
Where does 600488.SS trade?
Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) trades on the Shanghai Stock Exchange.
What sector is 600488.SS in?
Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tianjin Tianyao Pharmaceuticals Co., Ltd.?
Shuxiang Li is the chief executive officer of Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS).
Where is Tianjin Tianyao Pharmaceuticals Co., Ltd. headquartered?
Tianjin Tianyao Pharmaceuticals Co., Ltd. is headquartered in China.
Does 600488.SS pay a dividend?
Yes — Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600488.SS go public?
Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) completed its initial public offering in 2001.